Procurement Summary
Country: Russia
Summary: Supply of the Drug Adalimumab, Solution for Subcutaneous Administration, 40 Mg/0.8 Ml Within the Framework of the Implementation of the Decree of the Government of the Russian Federation Dated November 26, 2018 No. 1416 on the Procedure for Organi...
Deadline: 18 May 2026
Posting Date: 10 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141039031
Document Ref. No.: 0873400003926000382
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: 193429.71
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Supply of the drug Adalimumab, solution for subcutaneous administration, 40 mg/0.8 ml as part of the implementation of the Decree of the Government of the Russian Federation dated November 26, 2018 No. 1416 on the organizational procedure providing medications to persons with hemophilia, cystic fibrosis, pituitary dwarfism, Gaucher's disease, malignant neoplasms and lymphoid, hematopoietic and related diseases any, multiple sclerosis, hemolytic-uremic syndrome, juvenile arthritis with systemic onset, mucopolysaccharidosis types I, II and VI, unspecified aplastic anemia, hereditary deficiency m factors II (fibrinogen), VII (labile), X (Stuart-Prower), persons after organ and (or) tissue transplantation, as well as recognition of certain acts of the Government of the Russian Federation as invalid
Documents
Tender Notice